The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
In vivo magnetic resonance spectroscopy: basic methodology and clinical applications
Open accessAbstract
The clinical use of in vivo magnetic resonance spectroscopy (MRS) has been limited for a long time, mainly due to its low sensitivity. However, with the advent of clinical MR systems with higher magnetic field strengths such as 3 Tesla, the development of better coils, and the design of optimized radio-frequency pulses, sensitivity has been considerably improved. Therefore, in vivo MRS has become a technique that is routinely used more and more in the clinic. In this review, the basic methodology of in vivo MRS is described-mainly focused on (1)H MRS of the brain-with attention to hardware requirements, patient safety, acquisition methods, data post-processing, and quantification. Furthermore, examples of clinical applications of in vivo brain MRS in two interesting fields are described. First, together with a description of the major resonances present in brain MR spectra, several examples are presented of deviations from the normal spectral pattern associated with inborn errors of metabolism. Second, through examples of MR spectra of brain tumors, it is shown that MRS can play an important role in oncology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimation of metabolite concentrations from localized in vivo proton NMR spectra
Provencher, S. W. (1993) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910300604 · Cited by 3,655
Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR
Ardenkjær-Larsen, J. H., Fridlund, B., Gram, A., Hansson, G., Hansson, L., Lerche, M. H., Servin, R., Thaning, M., & Golman, K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1733835100 · Cited by 2,861
Spatial Localization in NMR Spectroscopy in Vivo
BOTTOMLEY, P. A. (1987) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1987.tb32915.x · Cited by 1,378
1H NMR chemical shift selective (CHESS) imaging
Haase, A., Frahm, J., Hanicke, W., & Matthaei, D. (1985) · Physics in Medicine and Biology · doi:10.1088/0031-9155/30/4/008 · Cited by 1,062
NMR chemical shift imaging in three dimensions.
Brown, T. R., Kincaid, B. M., & Ugurbil, K. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.11.3523 · Cited by 1,039
The signal-to-noise ratio of the nuclear magnetic resonance experiment
Hoult, D. I., & Richards, R. E. (2011) · Journal of Magnetic Resonance · doi:10.1016/j.jmr.2011.09.018 · Cited by 995
WET, a T1- and B1-Insensitive Water-Suppression Method for in Vivo Localized 1H NMR Spectroscopy
Ogg, R. J., Kingsley, R. B., & Taylor, J. S. (1994) · Journal of Magnetic Resonance, Series B · doi:10.1006/jmrb.1994.1048 · Cited by 732
Frahm, J., Bruhn, H., Gyngell, M. L., Merboldt, K. D., Hänicke, W., & Sauter, R. (1989) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910090110 · Cited by 709
Kreis, R., Ernst, T., & Ross, B. D. (1993) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910300405 · Cited by 681
In vivo proton spectroscopy in presence of eddy currents
Klose, U. (1990) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910140104 · Cited by 580
Michaelis, T., Merboldt, K. D., Bruhn, H., Hänicke, W., & Frahm, J. (1993) · Radiology · doi:10.1148/radiology.187.1.8451417 · Cited by 556
Howe, F. A., Barton, S. J., Cudlip, S. A., Stubbs, M., Saunders, D. E., Murphy, M., Wilkins, P., Opstad, K. S., Doyle, V. L., McLean, M. A., et al. (2003) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10367 · Cited by 539
Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS
Pouwels, P. J. W., & Frahm, J. (1998) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910390110 · Cited by 465
Creatine deficiency in the brain: A new, treatable inborn error of metabolism
Stöckler, S., Holzbach, U., Hanefeld, F., Marquardt, I., Helms, G., Requart, M., Hänicke, W., & Frahm, J. (1994) · Pediatric Research · doi:10.1203/00006450-199409000-00023 · Cited by 417 · cited 2×
“Complete absence of the Cre signal points directly to a defect in creatine synthesis, as in guanidino acetate methyltransferase deficiency (Stöckler et al. 1994) or in L-arginine glycine amidinotransferase deficiency (Item et al. 2001), or to a creatine transporter defect (Cecil et al. 2001).”
BackgroundMagnetic resonance spectroscopy of the human brain
Ross, B., & Bluml, S. (2001) · The Anatomical Record · doi:10.1002/ar.1058 · Cited by 411
Multisection proton MR spectroscopic imaging of the brain.
Duyn, J. H., Gillen, J., Sobering, G., van Zijl, P. C., & Moonen, C. T. (1993) · Radiology · doi:10.1148/radiology.188.1.8511313 · Cited by 356
Cramér–Rao bounds: an evaluation tool for quantitation
Cavassila, S., Deval, S., Huegen, C., van Ormondt, D., & Graveron‐Demilly, D. (2001) · NMR in Biomedicine · doi:10.1002/nbm.701 · Cited by 331
Pouwels, P. J. W., Brockmann, K., Kruse, B., Wilken, B., Wick, M., Hanefeld, F., & Frahm, J. (1999) · Pediatric Research · doi:10.1203/00006450-199910000-00019 · Cited by 309
Scheenen, T. W. J., Klomp, D. W. J., Wijnen, J. P., & Heerschap, A. (2008) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21302 · Cited by 293
Stöckler, S., Hanefeld, F., & Frahm, J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)04116-5 · Cited by 240
Magnetic resonance in biology and medicine
W.S.B (1988) · Journal of Magnetic Resonance (1969) · doi:10.1016/0022-2364(88)90074-1 · Cited by 235
Item, C. B., Stöckler-Ipsiroglu, S., Stromberger, C., Mühl, A., Alessandrì, M. G., Bianchi, M. C., Tosetti, M., Fornai, F., & Cioni, G. (2001) · The American Journal of Human Genetics · doi:10.1086/323765 · Cited by 233
Tate, A. R., Underwood, J., Acosta, D. M., Julià‐Sapé, M., Majós, C., Moreno‐Torres, À., Howe, F. A., van der Graaf, M., Lefournier, V., Murphy, M. M., et al. (2006) · NMR in Biomedicine · doi:10.1002/nbm.1016 · Cited by 228
Self-citationLi, B. S. Y., Wang, H., & Gonen, O. (2003) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(03)00181-4 · Cited by 202
Three-dimensional echo-planar MR spectroscopic imaging at short echo times in the human brain.
Posse, S., DeCarli, C., & Le Bihan, D. (1994) · Radiology · doi:10.1148/radiology.192.3.8058941 · Cited by 190
Cecil, K. M., Salomons, G. S., Ball, W. S., Wong, B., Chuck, G., Verhoeven, N. M., Jakobs, C., & DeGrauw, T. J. (2001) · Annals of Neurology · doi:10.1002/ana.79 · Cited by 181
Baslow, M. H. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(01)00095-x · Cited by 181
In vivo molecular imaging for planning radiation therapy of gliomas: An application of 1H MRSI
Nelson, S. J., Graves, E., Pirzkall, A., Li, X., Antiniw Chan, A., Vigneron, D. B., & McKnight, T. R. (2002) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10183 · Cited by 179
Leaning, M. S. (1984) · Measurement · doi:10.1016/0263-2241(84)90019-8 · Cited by 174
Magnetic resonance spectroscopy of neurotransmitters in human brain
Novotny, E. J., Fulbright, R. K., Pearl, P. L., Gibson, K. M., & Rothman, D. L. (2003) · Annals of Neurology · doi:10.1002/ana.10697 · Cited by 155
Clinical experience with 13C MRS in vivo
Ross, B. D., Lin, A., Harris, K. C., Bhattacharya, P. K., & Schweinsburg, B. C. (2003) · NMR in Biomedicine · doi:10.1002/nbm.852 · Cited by 151
Proton magnetic resonance spectroscopy in multiple sclerosis
Wolinsky, J. S., Narayana, P. A., & Fenstermacher, M. J. (1990) · Neurology · doi:10.1212/wnl.40.11.1764 · Cited by 145
Reduced phase encoding in spectroscopic imaging
Maudsley, A. A., Matson, G. B., Hugg, J. W., et al. (1994) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910310610 · Cited by 143
Quantitation of automated single‐voxel proton MRS using cerebral water as an internal reference
Soher, B. J., Hurd, R. E., Sailasuta, N., & Barker, P. B. (1996) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910360302 · Cited by 127
Damien Galanaud, E., Chinot, O. L., Nicoli, F., Sylviane Confort-gouny, A., Fur, Y. L., Barrié, M., Ranjeva, J., Fuentes, S., Viout, P., Figarella-Branger, D. F., et al. (2003) · Journal of neurosurgery · doi:10.3171/jns.2003.98.2.0269 · Cited by 126
Herminghaus, S., Pilatus, U., Möller‐Hartmann, W., Raab, P., Lanfermann, H., Schlote, W., & Zanella, F. E. (2002) · NMR in Biomedicine · doi:10.1002/nbm.793 · Cited by 125
Absence of N‐acetylaspartate in the human brain: Impact on neurospectroscopy?
Martin, E., Capone, A., Schneider, J., Hennig, J., & Thiel, T. (2001) · Annals of Neurology · doi:10.1002/ana.102.abs · Cited by 122
Moolenaar, S. H., Engelke, U. F. H., & Wevers, R. A. (2003) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/000456303321016132 · Cited by 121
Characterization of oligodendrogliomas using short echo time 1H MR spectroscopic imaging
Rijpkema, M., Schuuring, J., van der Meulen, Y. M., van der Graaf, M., Bernsen, H. J. J. A., Boerman, R. H., van der Kogel, A., & Heerschap, A. (2003) · NMR in Biomedicine · doi:10.1002/nbm.807 · Cited by 117
Insights into muscle diseases gained by phosphorus magnetic resonance spectroscopy
Argov, Z., L�fberg, M., & Arnold, D. L. (2000) · Muscle & Nerve · doi:10.1002/1097-4598(200009)23:9<1316::aid-mus2>3.0.co;2-i · Cited by 115
Willemsen, M. A. A. P., van der Graaf, M., van der Knaap, M. S., Heerschap, A., van Domburg, P. H. M. F., Gabreëls, F. J. M., & Rotteveel, J. J. (2004) · PubMed Central · Cited by 90
Janson, C., McPhee, S., Francis, J., Shera, D., Assadi, M., Freese, A., Hurh, P., Haselgrove, J., Wang, D., Bilaniuk, L., et al. (2006) · Neuropediatrics · doi:10.1055/s-2006-924734 · Cited by 82 · cited 1×
“Because of a deficiency in the enzyme aspartoacylase, NAA accumulates in the mitochondria and impairs myelin synthesis resulting in this severe whitematter disease (Janson et al. 2006).”
BackgroundBrockmann, K., Bjornstad, A., Dechent, P., Korenke, C. G., Smeitink, J., Trijbels, J. M. F., Athanassopoulos, S., Villagran, R., Skjeldal, O. H., Wilichowski, E., et al. (2002) · Annals of Neurology · doi:10.1002/ana.10232 · Cited by 81 · cited 2×
“…occurrence of high resonances of the polyols arabinitol and ribitol (*3.75 ppm) in ribose-5-phosphate isomerase deficiency (Van der Knaap et al. 1999) and the presence of a prominent succinic acid resonance (2.39 ppm) in succinic acid dehydrogenase or complex II deficiency (Brockmann et al. 2002).”
BackgroundInfluential1‐ 13 C glucose magnetic resonance spectroscopy of pediatric and adult brain disorders
Blüml, S., Moreno, A., Hwang, J., & Ross, B. D. (2001) · NMR in Biomedicine · doi:10.1002/nbm.679 · Cited by 78
Leukoencephalopathy associated with a disturbance in the metabolism of polyols
van der Knaap, M. S., Wevers, R. A., Struys, E. A., Verhoeven‐Duif, N. M., Pouwels, P. J. W., Engelke, U. F. H., Wj, F., Valk, J., & Jakobs, C. (1999) · Annals of Neurology · Cited by 78
Metabolomics: what's happening downstream of DNA.
Schmidt, C. W. (2004) · Environmental Health Perspectives · doi:10.1289/ehp.112-a410 · Cited by 74
Spectroscopic imaging: Basic principles
Škoch, A., Jírů, F., & Bunke, J. (2008) · European Journal of Radiology · doi:10.1016/j.ejrad.2008.03.003 · Cited by 70
Engelke, U. F. H., Kremer, B. P. H., Kluijtmans, L. A. J., van der Graaf, M., Morava, É., Loupatty, F. J., Wanders, R. J. A., Moskau, D., Loss, S., van den Bergh, E., et al. (2006) · NMR in Biomedicine · doi:10.1002/nbm.1018 · Cited by 59
MR Spectroscopy of Metabolic Disorders
Cecil, K. M. (2006) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2005.10.004 · Cited by 57
Sylvain, M., Arnold, D. L., Scriver, C. R., Schreiber, R. A., & Shevell, M. I. (1994) · Pediatric Neurology · doi:10.1016/0887-8994(94)90028-0 · Cited by 52
Efficient 1H to 31P polarization transfer on a clinical 3T MR system
Klomp, D. W. J., Wijnen, J. P., Scheenen, T. W. J., & Heerschap, A. (2008) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21733 · Cited by 50
Pietz, J., Lutz, T., Zwygart, K., Hoffmann, G. F., Ebinger, F., Boesch, C., & Kreis, R. (2003) · Journal of Inherited Metabolic Disease · doi:10.1023/b:boli.0000005648.75276.71 · Cited by 15
Cited by
Molecular imaging: current status and emerging strategies
Pysz, M. A., Gambhir, S. S., & Willmann, J. K. (2010) · Clinical Radiology · doi:10.1016/j.crad.2010.03.011 · Cited by 572
Alcohol and the Human Brain: A Systematic Review of Different Neuroimaging Methods
Bühler, M., & Mann, K. (2011) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01540.x · Cited by 310
Haroon, E., Woolwine, B. J., Chen, X., Pace, T. W., Parekh, S., Spivey, J. R., Hu, X. P., & Miller, A. H. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.25 · Cited by 154
Glutamate/glutamine and neuronal integrity in adults with ADHD: a proton MRS study
Maltezos, S., Horder, J., Coghlan, S., Skirrow, C., O'Gorman, R., Lavender, T. J., Mendez, M. A., Mehta, M., Daly, E., Xenitidis, K., et al. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.11 · Cited by 112
Hone-Blanchet, A., Edden, R. A., & Fecteau, S. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.11.008 · Cited by 110
“The metabolite NAA is critical to cellular regulatory processes, protein synthesis, and lipid production and is a marker of mitochondrial function (27) Decreases in NAA levels, reflecting cellular dysfunction or impaired functioning, have been correlated with neurologic lesions and psychopathology.”
Background
Metadata
- Authors
- van der Graaf, M.
- Venue
- European Biophysics Journal
- Published
- 2009-08-13
- Volume
- 39
- Issue
- 4
- Pages
- 527-540
- ISSN
- 0175-7571 (ISSN-L)
- 1432-1017
- OpenAlex
- W2148532836
- Cited by
- 275
- References
- 52
- FWCI
- 7.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.